Is Lantern Pharma Inc. (LTRN) a Buy, Sell, or Hold?
NASDAQ : LTRN
Lantern Pharma Inc. — Institutional Ownership
$2.8 USD
$0.05 (1.82%)
- Volume
- 42.53K
- Average Volume
- 215.21K
- Market Capitalization
- $35.73M
- P/E Ratio
- -1.93
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.74
- Year Low
- $1.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.87
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-08-04 | Empery Asset Management, LP | 1.32M | 9.99% |
| 2026-05-15 | BP DIRECTORS, LP | 26093.0 | 0.20% |
| 2026-05-15 | BIOS FUND II, LP | 64794.0 | 0.51% |
| 2026-05-15 | BIOS FUND II QP, LP | 211.57K | 1.66% |
| 2026-05-15 | BIOS FUND II NT, LP | 28324.0 | 0.22% |
| 2026-05-15 | BIOS CAPITAL MANAGEMENT, LP | 571.3K | 4.48% |
| 2026-05-15 | BIOS EQUITY PARTNERS II, LP | 304.68K | 2.39% |
| 2026-05-15 | BIOS FUND I QP, LP | 88769.0 | 0.70% |
| 2026-05-15 | BIOS EQUITY PARTNERS, LP | 266.62K | 2.09% |
| 2026-05-15 | CAVU MANAGEMENT, LP | 571.3K | 4.48% |
| 2026-05-15 | LESLIE W. KREIS | 571.3K | 4.48% |
| 2026-05-15 | CAVU ADVISORS, LLC | 571.3K | 4.48% |
| 2026-05-15 | BIOS ADVISORS GP, LLC | 571.3K | 4.48% |
| 2026-05-15 | AARON G.L. FLETCHER | 571.3K | 4.48% |
| 2026-05-15 | Bios Fund I, LP | 151.76K | 1.19% |
| 2026-04-16 | BP Directors, LP | 26093.0 | 0.20% |
| 2026-04-16 | Bios Equity Partners, LP | 420.8K | 3.70% |
| 2026-04-16 | Fletcher Aaron G.L. | 834.75K | 7.40% |
| 2026-04-16 | BIOS Advisors GP, LLC | 834.75K | 7.40% |
| 2026-04-16 | BIOS Capital Management, LP | 834.75K | 7.40% |
| 2026-04-16 | Bios Equity Partners II, LP | 413.95K | 3.70% |
| 2026-04-16 | BIOS Fund II, LP | 88029.0 | 0.80% |
| 2026-04-16 | BIOS Fund II NT, LP | 38479.0 | 0.30% |
| 2026-04-16 | BIOS Fund II QP, LP | 287.44K | 2.60% |
| 2026-04-16 | BIOS Fund I, LP | 249.04K | 2.20% |
| 2026-04-16 | BIOS Fund I QP, LP | 145.67K | 1.30% |
| 2026-04-16 | Cavu Advisors, LLC | 834.75K | 7.40% |
| 2026-04-16 | Cavu Management, LP | 834.75K | 7.40% |
| 2026-04-16 | Kreis Leslie W. | 834.75K | 7.40% |
| 2026-04-03 | Thomas A. Satterfield, Jr. | 570K | 5.10% |
| 2026-02-23 | BIOS FUND I QP, LP | 168.24K | 1.50% |
| 2026-02-23 | BIOS FUND II, LP | 101.66K | 0.91% |
| 2026-02-23 | BIOS FUND II QP, LP | 331.97K | 2.97% |
| 2026-02-23 | BIOS FUND II NT, LP | 44440.0 | 0.40% |
| 2026-02-23 | BP DIRECTORS, LP | 26093.0 | 0.23% |
| 2026-02-23 | BIOS EQUITY PARTNERS, LP | 481.95K | 4.31% |
| 2026-02-23 | BIOS CAPITAL MANAGEMENT, LP | 960.03K | 8.58% |
| 2026-02-23 | BIOS ADVISORS GP, LLC | 960.03K | 8.58% |
| 2026-02-23 | CAVU MANAGEMENT, LP | 960.03K | 8.58% |
| 2026-02-23 | CAVU ADVISORS, LLC | 960.03K | 8.58% |
| 2026-02-23 | LESLIE W. KREIS | 960.03K | 8.58% |
| 2026-02-23 | AARON G.L. FLETCHER | 960.03K | 8.58% |
| 2026-02-23 | BIOS EQUITY PARTNERS II, LP | 478.08K | 4.27% |
| 2026-02-23 | Bios Fund I, LP | 287.62K | 2.57% |
| 2025-06-13 | BIOS ADVISORS GP, LLC | 1.08M | 9.98% |
| 2025-06-13 | BIOS FUND I, LP | 323.34K | 3.00% |
| 2025-06-13 | BIOS FUND I QP, LP | 189.12K | 1.75% |
| 2025-06-13 | BIOS FUND II, LP | 114.27K | 1.06% |
| 2025-06-13 | BIOS FUND II QP, LP | 373.18K | 3.46% |
| 2025-06-13 | BIOS FUND II NT, LP | 49957.0 | 0.46% |
| 2025-06-13 | BP DIRECTORS, LP | 26093.0 | 0.24% |
| 2025-06-13 | BIOS EQUITY PARTNERS, LP | 538.54K | 4.99% |
| 2025-06-13 | BIOS EQUITY PARTNERS II, LP | 537.41K | 4.98% |
| 2025-06-13 | CAVU MANAGEMENT, LP | 1.08M | 9.98% |
| 2025-06-13 | BIOS CAPITAL MANAGEMENT, LP | 1.08M | 9.98% |
| 2025-06-13 | CAVU ADVISORS, LLC | 1.08M | 9.98% |
| 2025-06-13 | LESLIE W. KREIS | 1.08M | 9.98% |
| 2025-06-13 | AARON G.L. FLETCHER | 1.08M | 9.98% |
| 2021-02-16 | of 17 Pages | 672.76K | 6.40% |
| 2021-02-16 | Arunkumar Asaithambi | 470.46K | 4.50% |
| 2021-02-16 | of 17 Pages | 211.29K | 2.00% |
| 2021-02-16 | of 17 Pages | 211.29K | 2.00% |
| 2021-02-16 | of 17 Pages | 147.5K | 1.40% |
| 2021-02-16 | of 17 Pages | 313.96K | 3.00% |
| 2021-02-16 | of 17 Pages | 525.26K | 5.00% |
| 2021-02-16 | of 17 Pages | 147.5K | 1.40% |
| 2021-02-16 | of 17 Pages | 672.76K | 6.40% |
| 2021-02-16 | of 17 Pages | 147.5K | 1.40% |
| 2021-01-25 | Empery Asset Management, LP | 700K | 6.66% |
| 2021-01-25 | Ryan M. Lane | 700K | 6.66% |
| 2021-01-25 | Martin D. Hoe | 700K | 6.66% |
| 2020-06-23 | LESLIE WAYNE KREIS, JR. | 1.97M | 30.60% |
| 2020-06-23 | CAVU MANAGEMENT, LP | 1.97M | 30.60% |
| 2020-06-23 | BIOS CAPITAL MANAGEMENT, LP | 1.97M | 30.60% |
| 2020-06-23 | CAVU ADVISORS, LLC | 1.97M | 30.60% |
| 2020-06-23 | AARON GLENN LOUIS FLETCHER | 1.97M | 30.60% |
| 2020-06-23 | BP DIRECTORS, LP | 33046.0 | 0.50% |
| 2020-06-23 | BIOS EQUITY PARTNERS II, LP | 1.04M | 16.50% |
| 2020-06-23 | BIOS ADVISORS GP, LLC | 1.97M | 30.60% |
| 2020-06-23 | BIOS FUND I, LP | 564.04K | 9.00% |
| 2020-06-23 | BIOS FUND I QP, LP | 329.9K | 5.30% |
| 2020-06-23 | BIOS FUND II, LP | 221.52K | 3.60% |
| 2020-06-23 | BIOS FUND II QP, LP | 723.61K | 11.50% |
| 2020-06-23 | BIOS FUND II NT, LP | 96868.0 | 1.60% |
| 2020-06-23 | BIOS EQUITY PARTNERS, LP | 926.99K | 14.60% |
| 2020-06-23 | SCHEDULE 13D | 12.0 | 14.00% |
| 2020-06-19 | s | 495.49K | 7.40% |
LTRN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.03 | 10.9M | $33.02M | $4.42M | $78.54M | $107.14M |
| 2024-12-31 | $3.19 | 10.76M | $34.33M | $7.51M | $243.66K | $27.06M |
| 2023-12-31 | $4.28 | 10.84M | $46.41M | $21.94M | $234.47K | $24.7M |
| 2022-12-31 | $6.04 | 10.85M | $65.54M | $37.2M | $52890 | $28.39M |
| 2021-12-31 | $7.98 | 10.9M | $87.02M | $51.52M | $204.95K | $35.7M |
| 2020-12-31 | $19.25 | 6.22M | $119.75M | $19.23M | $108.5K | $100.63M |
| 2019-12-31 | $14.95 | 6.27M | $93.66M | $1.23M | -$ | $92.43M |
| 2018-12-31 | $14.95 | 6.22M | $92.95M | $445.16K | -$ | $92.51M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.37 | 11.25M | $15.42M | $4.92M | $59076 | $10.56M |
| 2025-12-31 | $3.03 | 10.9M | $33.02M | $4.42M | $78539 | $28.68M |
| 2025-09-30 | $4.35 | 10.83M | $47.13M | $8.39M | $93954 | $38.83M |
| 2025-06-30 | $3.16 | 10.78M | $34.08M | $6.06M | $145.04K | $28.16M |
| 2025-03-31 | $3.54 | 10.78M | $38.18M | $6.38M | $194.93K | $32M |
| 2024-12-31 | $3.19 | 10.78M | $34.4M | $7.51M | $243.66K | $27.14M |
| 2024-09-30 | $3.67 | 10.76M | $39.5M | $8.1M | $291.24K | $31.69M |
| 2024-06-30 | $4.52 | 10.76M | $48.63M | $12.98M | $218.7K | $35.87M |
| 2024-03-31 | $9.51 | 10.74M | $102.16M | $18.36M | $193.58K | $84M |
| 2023-12-31 | $4.28 | 10.8M | $46.23M | $21.94M | $234.47K | $24.52M |
| 2023-09-30 | $3.41 | 10.86M | $37.02M | $25.57M | $274.53K | $11.73M |
| 2023-06-30 | $5.64 | 10.86M | $61.23M | $28.42M | $313.86K | $33.12M |